PLUS1
40.12
-0.43 (-1.06%)
-0.43 (-1.06%)
Upgrade to Real-Time
Afterhours (Closed)
| Volume | 590,900 |
|
|||||
| News | - | ||||||
| Day High | 41.25 | Low High |
|||||
| Day Low | 39.5026 | ||||||
| Stock Name | Stock Symbol | Market | Stock Type |
|---|---|---|---|
| Amylyx Pharmaceuticals Inc | AMLX | NASDAQ | Common Stock |
| Price Change | Price Change % | Stock Price | Last Trade
|
|
|---|---|---|---|---|
| -0.43 | -1.06% | 40.12 | 12:00:00 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 41.00 | 39.5026 | 41.25 | 40.12 | 40.55 |
| Trades | Stocks Traded | VWAP | Financial Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 11,933 | 590,900 | US$ 40.18 | US$ 23,741,642 | - | 6.51 - 41.25 |
| Last Trade | Type | Quantity | Price | Currency |
|---|---|---|---|---|
| 09:01:47 | 3 | US$ 40.12 | USD |
Period:
Draw Mode:
Amylyx Pharmaceuticals Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| US$ 2.66B | 66.26M | 36.19M | US$ - | US$ - | -1.73 | -12.30 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | US$ - | - | - | 9.80% |
Amylyx Pharmaceuticals News
| Date | Time | Source | News Article |
|---|---|---|---|
| 17/1/2023 | 18:00 | Business Wire | Amylyx Pharmaceuticals Announces Exclusive AMX0035.. |
| 12/1/2023 | 08:08 | Edgar (US Regulatory) | Annual Statement of Changes in Beneficial Ownership (5) |
| 23/11/2022 | 01:00 | Business Wire | Amylyx Pharmaceuticals to Participate in the Evercore ISI.. |
| 14/11/2022 | 14:55 | TipRanks | SVB Securities Keeps Their Buy Rating on Amylyx.. |
| 12/11/2022 | 00:45 | TipRanks | Amylyx Pharmaceuticals Inc (AMLX) Receives a Buy from H.C... |
| 11/11/2022 | 08:16 | Edgar (US Regulatory) | Quarterly Report (10-q) |
| 11/11/2022 | 08:08 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 11/11/2022 | 08:01 | Business Wire | Amylyx Pharmaceuticals Reports Third Quarter 2022 Financial.. |
| 04/11/2022 | 07:05 | Business Wire | Amylyx Pharmaceuticals to Report Third Quarter 2022.. |
| 03/11/2022 | 07:02 | Edgar (US Regulatory) | Current Report Filing (8-k) |
| 12/10/2022 | 22:02 | TipRanks | These Analysts Have a 100% Success Rate on Mattel and Amylyx |
| 12/10/2022 | 07:01 | Business Wire | Amylyx Pharmaceuticals Announces Closing of Upsized Public.. |
Historical AMLX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 35.55 | 41.25 | 32.7433 | 38.31 | 1,257,402 | 4.57 | 12.86% |
| 1 Month | 35.23 | 41.25 | 32.7433 | 37.17 | 880,417 | 4.89 | 13.88% |
| 3 Months | 34.76 | 41.25 | 32.69 | 36.32 | 807,803 | 5.36 | 15.42% |
| 6 Months | 21.22 | 41.25 | 15.8001 | 30.82 | 1,172,472 | 18.90 | 89.07% |
| 1 Year | 18.84 | 41.25 | 6.51 | 25.12 | 1,005,084 | 21.28 | 112.95% |
| 3 Years | 21.00 | 41.25 | 6.51 | 24.98 | 981,610 | 19.12 | 91.05% |
| 5 Years | 21.00 | 41.25 | 6.51 | 24.98 | 981,610 | 19.12 | 91.05% |